Human urine-derived renal epithelial cells provide insights into kidney-specific alternate splicing variants by Molinari E et al.
European Journal of Human Genetics
https://doi.org/10.1038/s41431-018-0212-5
ARTICLE
Human urine-derived renal epithelial cells provide insights into
kidney-specific alternate splicing variants
Elisa Molinari1 ● Eva Decker2 ● Holly Mabillard3 ● James Tellez4 ● Shalabh Srivastava1 ● Shreya Raman5 ●
Katrina Wood5 ● Caroline Kempf6 ● Sumaya Alkanderi1 ● Simon A. Ramsbottom1 ● Colin G. Miles1 ● Colin A. Johnson7 ●
Friedhelm Hildebrandt 8 ● Carsten Bergmann2,9 ● John A. Sayer 1,3
Received: 23 March 2018 / Revised: 13 June 2018 / Accepted: 19 June 2018
© The Author(s) 2018. This article is published with open access
Abstract
The majority of multi-exon genes undergo alternative splicing to produce different mRNA transcripts and this may occur in a
tissue-specific manner. Assessment of mRNA transcripts isolated from blood samples may sometimes be unhelpful in
determining the affect on function of putative splice-site variants affecting kidney-specific mRNA transcripts. Here we present
data demonstrating the power of using human urine-derived renal epithelial cells (hUREC) as a source of kidney RNA. We
report clinical and molecular genetic data from three affected cases from two families all with end-stage renal disease by 15
years of age. In both families, heterozygous variants which are predicted to effect function in NPHP3 were found on one
allele, in combination with a synonymous SNV (c.2154C>T; p.Phe718=), 18 base pairs from the exon–intron boundary
within exon 15 of NPHP3. The only mRNA transcript amplified from wild-type whole blood showed complete splicing out of
exon 15. Urine samples obtained from control subjects and the father of family 2, who carried the synonymous SNV variant,
were therefore used to culture hUREC and allowed us to obtain kidney-specific mRNA. Control kidney mRNA showed
retention of exon 15, while the mRNA from the patient’s father confirmed evidence of a heterozygous alternate splicing of
exon 15 of NPHP3. Analysis of RNA derived from hUREC allows for a comparison of kidney-specific and whole-blood
RNA transcripts and for assessment of the effect on function of putative splice variants leading to end-stage kidney disease.
Introduction
Next-generation sequencing techniques, including whole-
exome sequencing (WES), has seen a huge surge in gene
discovery, exemplified by gene discovery in various forms
of inherited renal diseases. Indeed, ciliopathy exome
capture and WES approaches have been successful in
identifying numerous new genetic forms of nephro-
nophthisis, an autosomal recessive renal ciliopathy [1–3].
Similarly, isolation of whole-blood RNA followed by RT-
PCR strategies for identifying variants in sets of large
genes underlying certain phenotypes has been successful
[4]. Routine genetic diagnostics typically verify splice-
site variants identified by genetic and genomic approaches
using whole-blood or fibroblast RNA to assess for aber-
rant splicing. This has the advantage of assessing RNA
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directly from the patient (rather than using in silico tools)
but the disadvantage is that RNA from affected tissues is
not usually available and the gene of interest may not be
expressed in the available tissue. For example, assessment
of mRNA transcripts isolated from blood samples may be
unhelpful in determining the functional effect of putative
splice-site variants affecting kidney-specific mRNA tran-
scripts. In the modern post-genome sequencing era,
interpretation and functional validation of genomic var-
iants has become vital in the understanding of disease.
Genetic variants may have consequences on RNA pro-
cessing, including exon skipping, intron inclusion, and
cryptic splicing. The majority of multi-exon genes
undergo alternative splicing to produce different mRNA
transcripts and this occurs in a tissue-specific manner [5].
Efforts to understand tissue-specific RNA transcripts have
been made [6], which will hopefully increase our under-
standing of genotype/phenotype correlation in inherited
diseases and allow the verification of the consequences of
genomic variants in appropriate tissues.
Nephronophthisis is a chronic interstitial nephropathy
and an autosomal recessive form of childhood kidney fail-
ure. It has numerous genetic causes, although the under-
lying molecular genetic change remains elusive in around
50% of cases, due to either unknown genetic causes or
hidden variants in known genes. A molecular genetic
diagnosis is important to understand genotype/phenotype
correlations, prevent the need for a renal biopsy, and to
perform screening of at risk individuals.
Here we present data demonstrating the power of using
human urine-derived renal epithelial cells (hUREC) as a
liquid biopsy of the kidney in order to isolate tissue-specific
RNA, to demonstrate the functional effect of a genomic
DNA variant in NPHP3 found in families with previously
undiagnosed end-stage renal disease (ESRD).
Methods
All patients consented to this study. Ethical approval was
obtained from the UK National Research Ethics Service
Committee Northern and Yorkshire (09/H0903/36). Fol-
lowing informed and written consent, blood samples were
obtained from affected patients and their relatives and
healthy gender and age-matched controls. WES was per-
formed as previously described [7] and targeted sequence
analysis was performed using a customized sequence cap-
ture library [8]. hURECs were isolated from urine collected
from the father of family 2 and healthy age-matched donors
and cultured as previously described [9, 10]. Gene variants
have been submitted to www.LOVD.nl/NPHP3 (patient IDs
00164069, 00164068, and 00164805). Full details of
methodology are provided in Supplementary Data. Ta
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Results
Clinical features and genomic investigations of two
families with unexplained ESRD
In the first family, a 14-year-old presented chronic kidney
disease stage 4 which progressed to unexplained ESRD
by 15 years of age (Table 1). The parents were non-
consanguineous and white European. There was no family
history of renal disease. Renal ultrasound showed
increased echogenicity and loss of cortico-medullary dif-
ferentiation and a renal biopsy showed chronic interstitial
fibrosis and tubular atrophy suggestive of nephro-
nophthisis (Table 1).
In the second family, two siblings presented with con-
genital hepatic fibrosis and unexplained ESRD. The first
sibling received a combined kidney and liver transplant
aged 15 years (Table 1). A renal biopsy had demonstrated
glomerular sclerosis and interstitial fibrosis with features
suggestive of nephronophthisis (Supplementary Fig. S1).
The second sibling reached ESRD at the age of 13 years and
had received a renal transplant followed by a liver transplant
1 year later. The family was white British and non-
consanguineous and had an unaffected male sibling
(Table 1).
In Family 1, targeted exon capture and sequencing
of a ciliopathy panel of 121 genes, as previously reported
[8, 11], identified a variant predicted to affect function in
NPHP3 (NM_153240.3, c.3003del; p.(Phe1001Leufs*61))
in combination with a synonymous SNV (c.2154C>T; p.
Phe718=). The variants were present in compound het-
erozygous state with the frameshift variant inherited
maternally and the synonymous change inherited paternally
(Table 2, Fig. 1).
In family 2, following exclusion of PKHD1 variants by
direct sequencing, WES revealed a single heterozygous
variant predicted to affect function (c.2694-2_2694-1delAG)
in NPHP3, segregating from the mother, combined with the
above-mentioned synonymous SNV in NPHP3 (c.2154C>T;
p.Phe718=), segregating from the father (Table 2). The
functional effect of the c.2694-2_2694-1delAG variant in
leading to abnormal splicing was confirmed using RT-PCR
from whole-blood RNA in the affected siblings of family 2
(Supplementary Fig. S2). In both families, the rare synon-
ymous SNV in NPHP3 (Table 2) was initially assumed to
be benign and has been reported within ClinVar as “likely
benign” (SCV000316262.1). However, given this was
identified in three individuals from two different families
with overlapping clinical phenotypes and the fact that no
other known ciliopathy gene variants affecting function had
been identified using NGS approaches in these families,
additional investigations were undertaken.
The NPHP3 c.2154C>T variant is near an exon–intron
boundary (exon 15–intron 15), and therefore may have been
implicated in abnormal splicing of exon 15 of NPHP3. In
silico tools, including Human Splicing Finder suggested a
functional effect, with probable disruption of exonic spli-
cing motifs (Table 2).
mRNA isolated from whole blood from the affected
patients from family 2 and unaffected healthy controls all
showed complete splicing out of exon 15 of NPHP3, which
was confirmed by Sanger sequencing, suggesting RNA
splicing of this exon was tissue specific (Fig. 1). Both
affected patients in family 2 had received a renal transplant,
therefore RNA isolated from their urine would represent the
donor. Instead, urine samples obtained from the father in
family 2 and healthy control subjects were used to culture
hUREC, allowing us to obtain kidney-specific mRNA.
Using these tissue-derived mRNA samples, RT-PCR across
exon 15 of NPHP3 in control kidney mRNA showed
retention of exon 15, confirmed by Sanger sequencing,
while the RNA from the father from family 2 showed het-
erozygous alternative splicing in NPHP3, confirming a
kidney-specific loss of function of the c.2154C>T allele.
Discussion
Variants that affect function in NPHP3 can lead to a variety
of clinical presentations, as emphasized by the two families
reported here. Although reported initially as a cause of
adolescent NPHP [12], variants that affect function in
Table 2 In silico analysis of NPHP3 variants
NPHP3 varianta MutationTaster Human Splicing
Finder
ExAC gnomAD
c.3003del; p.(Phe1001Leufs*61) Disease causing, likely NMD n/a Not in ExAC Not in gnomAD
c.2694-2_2694-1delAG; p.?; Disease causing—splice acceptor variant
(HGMD CD082161; rs751527253)
Acceptor site loss 43 alleles in
121,030 alleles
77 alleles in
277,098 alleles
c.2154C>T; p.Phe718= Disease causing (rs558637226) #Possible branch
point motif broken
1 allele in
121,283 alleles
3 alleles in
277,341 alleles
NMD nonsense-mediated decay
aNucleotide reference sequence: NM_153240.3, genomic reference sequence NG_008130.1 #ESEfinder, predicts an exon splicing enhancer (ESE)
site is abolished thus inhibiting the binding of splicing enhancer proteins leading to aberrant splicing
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NPHP3 are a prominent cause of infantile NPHP and may
present antenatally with enlarged cystic kidneys [13] and
sometimes cause the perinatally lethal Meckel Syndrome
[14]. The wide phenotypic variability, especially in extra-
renal manifestations may sometimes be explained by the
predicted functional effect of the variant alleles [14]. A
NPHP3 variant predicted to influence splicing may have
variable effects, depending on the transcript generated
Fig. 1 Molecular genetic investigation and tissue-specific RT-PCR
reveals a functional effect of a synonymous NPHP3 allele. a, b Ped-
igree diagrams (males squares, females circles, probands arrowed) and
sequence chromatograms showing biallelic variants in NPHP3 in
affected patient in a Family 1 and b Family 2. c Genomic map and RT-
PCR strategy to detect abnormal splicing of exon 15 of NPHP3, with
primers arrowed. Exons are numbered as in Olbrich et al. [12]. d RT-
PCR using RNA isolated from wild-type (WT) hUREC, WT Whole
blood and family 2 paternal hUREC. Note paternal RNA is compound
heterozygous for alternate splicing of exon 15 of NPHP3
(NM_153240.3: c.2154C>T; r.2154c>u). e Sanger sequencing con-
firms alternate splicing of NPHP3 exon 15 in wild-type whole-blood
RNA. f Sanger sequencing confirms inclusion of exon 15 in RNA
derived from wild-type hUREC
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and any tissue-specific effects on splicing. The fact that all
three affected patients we report here reached ESRD
from 13–15 years of age is typical of NPHP. The variable
extra renal phenotypes, including liver fibrosis, is also
typical.
The original description of NPHP3 variants that effect
function, leading to nephronophthisis in man, noted alter-
nate mRNA transcripts of NPHP3 were expressed, with
variation in splicing of exons 3b, 13, and 15 [12]. For
example, the AL832877 transcript of NPHP3 is differen-
tially spliced, omitting exon 15, and was cloned from
human lymph node, whereas the clone CA396561, derived
from human retinal pigment epithelium, includes exon 15.
The full-length cDNA of NPHP3 encodes for a 1330 amino
acid protein. Here we have shown that in white blood cell
RNA, there is alternate splicing of exon 15 of NPHP3. The
consequences of loss of exon 15, which has 83 nucleotides,
is predicted to lead to a change in reading frame of the
downstream exons of NPHP3 and a truncated protein of just
704 amino acids. The precise function of this predicted
alternate transcript is unknown, but the transcript may be
subject to nonsense-mediated decay.
This report suggests that synonymous changes in known
disease causing genes (such as the known NPHP genes)
cannot automatically be filtered out from WES datasets
before an in silico assessment of influence on splicing has
been determined. The significance of synonymous variants
in PKD1, one of the genes underlying autosomal dominant
polycystic kidney disease, has recently been described [15].
Here two synonymous variants in PKD1 were shown to
induce pre-mRNA splicing defects [15]. In the case of
genetically unsolved recessive cystic kidney diseases such
as nephronophthisis, the finding of one variant which affects
function, such as a heterozygous nonsense variant in a
known genetic cause of the disease (e.g. NPHP1), should
prompt a review of synonymous variants within the same
gene to see if a synonymous variant may be the second
allele which affects function.
Conclusion
In conclusion, we confirm the functional effect of a
synonymous single-nucleotide polymorphism in NPHP3 by
determining alternate splicing in kidney RNA isolated from
urine-derived renal epithelial cells. This system will allow
for a comprehensive comparison of kidney-specific and
whole-blood RNA transcripts and for the ex vivo assess-
ment of the functional effect of putative splice variants.
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